| [1] |
白孝雪, 张研蓓.肺癌肿瘤标志物检测的研究现状[J].临床肺科杂志, 2011, 16(2): 259-260.
|
| [2] |
刘红, 李海燕, 王静, 等.肿瘤标志物联合胸部影像学在肺癌早期诊断中的价值[J].实用医学杂志, 2012, 28(12): 2078-2080.
|
| [3] |
Kasprzak A, Zabel M, Biczysko W.Selected markers(Chromogranin A, neuron-specific enolase, Synaptophysin, proteingene product 9.5)in diagnosis of neuroendocrine pulmonary tumours[J].Pol J pathol, 2007, 58(1): 23-33.
|
| [4] |
Ekman S, Eriksson P, Bergstron S, et al.Clinical value of using serological cytokeratins of therspcific markers in thoracic malignancie[J].Anticancer Res, 2007, 27(58): 3545-3553.
|
| [5] |
Monteiro E, Varzim G, Crespo M, et al.Varzim GME, CYFRA21-1, TPS and SCC in Squamous cell carcinoma larynx[J].An Otorrinlaringol Ibero Am, 2003, 30(5): 4674-4679.
|
| [6] |
Haizakis KD, Froudarakis ME, Bouros D, et al.Prognosic value of serum tumor markers in patients with lung cancer[J].Respiration, 2002, 69(1): 26-37.
|
| [7] |
Shitrit D, Zingerman B, Shitrit AB, et al.Diagnostic Value of CYFRA21-1, CEA, CA19-9, CA15-3, CA125 assay in pleural effusion: analysis of 116 cases and review of the litersture[J].Oncologist, 2005, 10(2): 501-507.
|
| [8] |
郝青林, 孙士波, 谭波, 等.糖类抗原联合检测对肺癌合并胸腔积液的诊断价值[J].国际呼吸杂志, 2008, 28(18): 1094-1096.
|
| [9] |
Schiller JH, Harring TD, Belani CP, et al.Comparison of four chemotherapy regimens for advanced non-small cell lung cancer[J].N Engl J Med, 2002, 346(2): 92-98.
|
| [10] |
Ustiln H, Borazan A, Bilgicli N, et al.Diagnostic value of tumoural markers in pleural effusions[J].Int J Clin Pract, 2004, 58: 22-25.
|
| [11] |
Takahide K, Hiroaki S, Hiroichi I, et al.Serum of CA19-9 in patients with nonmalignant respiratory disease[J].J Clin Lab Anal, 2007, 21(2): 103-106.
|
| [12] |
陈铎, 李为民, 王冬梅, 等.联合检测血清肿瘤标志物在肺癌诊断中的价值[J].四川大学学报:医学版, 2008, 39(5): 832-835.
|
| [13] |
Li CS, Cheng BC, Ge W, et al.Clinical value of CYFRA21-1, NSE, CA153, CA199, CA125 assay in the elderly patients with pleural effusions.Int J Clin Pract[J].2007, 61(3): 444-448.
|